Zuragard

(Isopropyl Alcohol)

Phase 2Small molecule

ZZurex Pharma, Inc.

Zuragard is one of 10 small molecule programs targeting Injury. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Patents

Pipeline

Status by Indication[3][1]

Indication

CLENot yet recruiting

CLEPhase 2

Not yet recruiting

Competition

Competitive Landscape

14 competitors in CLE

#DrugCompanyPhaseTrials

Zytiga

Johnson & Johnson

Phase 3

1 2

Zuragard

ZZurex Pharma, Inc.

Phase 2

1 3

Keto Acid

UUniversity Hospital, Clermont-Ferrand

Phase 3

1 4

Brethine

Sanofi

Preclinical

2 5

ATR-258

AAtrogi AB

Phase 2

1 6

Povidine-Iodine

MMidAtlantic Retina

Phase 2

1 7

Pharmacokinetics

Pfizer

Phase 1

1 8

Clenbuterol

UUniversity of Copenhagen

Preclinical

1 9

Triptorelin Acetate

Ipsen

Preclinical

1 10

Recombinant Hcg

UUniversitair Ziekenhuis Brussel

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Nausea2 trials

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Not yet recruiting·MM.D. Anderson Cancer Center·Phase 2·NCT04181463·112 enrolled

Inhaled Isopropyl Alcohol Versus Placebo to Manage Nausea at Electronic Dance Music Festivals

Completed·AAnthony Seto·N/A·NCT04307550·55 enrolled

Chlorhexidine1 trial

Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination

Completed·UUniversidad de Guanajuato·Phase 3·NCT01361997·1,102 enrolled

Injury1 trial

Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping Injury

Completed·JJohnson & Johnson Consumer and Personal Products Worldwide·N/A·NCT02320695·60 enrolled

Skin1 trial

AvenovaTM as a Sterile Skin Preparation Agent

Completed·UUniversity of Miami·Phase 1·NCT02990013·21 enrolled

CLE1 trial

Cleaning the Biopsy Needle in TRUS Bx

Not yet recruiting·HHitit University·Phase 2·NCT06836271·200 enrolled

Regulatory

FDA Approval Timeline[4]

Apr 26, 2019

ZURAGARD

NDA NDA210872

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Isopropyl Alcohol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Isopropyl Alcohol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Isopropyl Alcohol. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA210872). U.S. Food & Drug Administration.
[5]
FDA Orange Book — Patent and exclusivity data for Zuragard. U.S. Food & Drug Administration.
[6]
SEC EDGAR — Zurex Pharma, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: ZZurex Pharma, Inc.

Patent Landscape[5]

Patent Cliff

May 23, 2028

Earliest patent expiration — generic entry possible after this date

Patent #Expires

9629368May 23, 2028

8703828May 23, 2028

8389583Aug 9, 2029

10688291Dec 20, 2034

9844654Apr 24, 2036

Zuragard

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Nausea2 trials

Chlorhexidine1 trial

Injury1 trial

Skin1 trial

CLE1 trial

FDA Approval Timeline[4]

References

Drug Info

Quick Facts

Patent Landscape[5]

Related News